About
The Bioculture Group

Founded in Mauritius in 1985, the Bioculture Group is a globally integrated life sciences organization operating across ethical animal care, preclinical research, and biomedical innovation. With more than four decades of experience and a growing footprint in the United States, Bioculture connects responsible stewardship with scientific progress to support the development of life-changing therapies.

Our work spans across the biomedical value chain, from ethical sourcing to translational research, guided by long-standing commitments to welfare, compliance, and sustainability.

Story of Bioculture Group

Bioculture was founded by Mary-Ann and Owen Griffiths with a belief that medical research and biodiversity protection must advance together. Established in Mauritius, the company pioneered ethical, purpose-bred non-human primate (NHP) programs at a time when global standards were still emerging.

Over time, Bioculture evolved from a single breeding operation into a vertically integrated life sciences group, expanding into the United States and into preclinical and translational research.

Timeline Arrow

2025

Launch of AnewCRO

Timeline Dot

2024

Investment in Franklin Biolabs

Timeline Dot

2023 onwards

Strategic growth focused on diversifying across the biomedical value chain with expansion in research services

Timeline Dot

2019 – 2020

An uptick in demand opens a rapid growth opportunity, with the workforce in Mauritius increasing fivefold

Timeline Dot

2009 – 2018

Downward trend for industry following Global Economic Crisis. Company focused on cost management and strengthening efficiency in operations

Timeline Dot

2012

Builds supply chain in the US, and sets up BCUS – site in Florida with CDC approved quarantine, and holding of animals for clients

Timeline Dot

2006

Bioculture launches its purpose-build animal data management software and obtains its AAALAC accreditation, which is to this date maintained.

Timeline Dot

1990 – 2009

Steady growth with a focus on building robust operations to deliver the gold standard in NHP models for Biomedical Research

Timeline Dot

1999

BCM becomes ISO 9001 certified

Timeline Dot

1992

Specific Pathogen Free (SPF) Status of Mauritian Cynomolgus Macaques is confirmed in a publication of Primates (vol. 33, 1992)

Timeline Dot

1985

Bioculture (Mauritius) Ltd founded, pioneering supply of MCMs for Biomedical research

Timeline Dot
Our Vision

To contribute meaningfully to breakthroughs in medical research
for the benefit of humankind.

What Makes Us Unique

Mauritian Roots, Global Presence

Bioculture’s foundation in Mauritius gives it access to one of the world’s most consistent & ethically managed cynomolgus macaque populations. This heritage is combined with a strategic U.S. presence, enabling full traceability and compliance across breeding, quarantine, research & translational development.

Science Meets Biodiversity

Our work bridges two worlds: the natural environment that sustains life & the scientific pursuit that saves it. Every research & every study we support is grounded in respect for ecological balance & animal welfare.

Strong Values, Continuous Growth

Family leadership and corporate governance ensure long-term stability, reinvestment, and innovation. From small beginnings, Bioculture has become a multinational partner to leading pharmaceutical & academic institutions.

Bioculture Group Companies

Our companies offer a broad range of services that support biomedical research in their specialized niche, and are united by a shared commitment to responsible medical science & care.

The founding company of the Bioculture Group, specialized in ethical breeding & export of SPF cynomolgus macaques. Bioculture (Mauritius) Ltd is the pioneer in supplying Mauritian origin NHPs for biomedical research worldwide

A full suite contract research organisation (CRO) delivering on the promise of cell & gene therapy.

U.S.-based quarantine and holding facility providing regulatory-compliant importation, acclimation, and client coordination for non-human primates.

A discovery-focused CRO specializing in translational science, advancing novel therapies through its expertise in non-human primates.

The founding company of the Bioculture Group, specialized in ethical breeding and export of SPF cynomolgus macaques.

A full suite contract research organisation (CRO) delivering on the promise of cell and gene therapy.

U.S.-based quarantine and holding facility providing regulatory-compliant importation, acclimation, and client coordination for non-human primates.

A discovery-focused CRO specializing in translational science, advancing novel therapies through its expertise in non-human primates.